Biofrontera (BFRI) Asset Utilization Ratio (2021 - 2026)
Biofrontera (BFRI) posted quarterly Asset Utilization Ratio of 1.9 for Q4 2025, up 3.2% year-over-year from 1.84 in Q4 2024, and down 9.27% quarter-over-quarter from 2.09 in Q3 2025.
Biofrontera (BFRI) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Biofrontera's Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 1.9 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio rose 3.2% year-over-year to 1.9; the TTM figure through Dec 2025 stood at 1.9 (up 3.2% YoY), while the FY2025 annual figure was 1.65, up 10.35% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 1.9, down from 2.09 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 2.13 in Q2 2025, with the low at 0.01 in Q4 2021.
- The 5-year median for Asset Utilization Ratio is 1.27 (2024), against an average of 1.14.
- The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio jumped 7068.62% in 2022, then increased 3.2% in 2025.
- Biofrontera's Asset Utilization Ratio stood at 0.01 in 2021, then surged by 7068.62% to 0.54 in 2022, then soared by 102.93% to 1.1 in 2023, then soared by 67.3% to 1.84 in 2024, then grew by 3.2% to 1.9 in 2025.
- Business Quant data shows BFRI's Asset Utilization Ratio at 1.9 in Q4 2025, 2.09 in Q3 2025, and 2.13 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Biofrontera | 19.06 Mn | 14.35 Mn | 9.59 Mn | 1.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 |
| Dec 31, 2025 | 1.90 |
| Sep 30, 2025 | 2.09 |
| Jun 30, 2025 | 2.13 |
| Mar 31, 2025 | 1.96 |
| Dec 31, 2024 | 1.84 |
| Sep 30, 2024 | 1.76 |
| Jun 30, 2024 | 1.53 |
| Mar 31, 2024 | 1.27 |
| Dec 31, 2023 | 1.10 |
| Mar 31, 2023 | 0.60 |
| Dec 31, 2022 | 0.54 |
| Sep 30, 2022 | 0.07 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | 0.21 |
| Dec 31, 2021 | 0.01 |